PSX · Verdict

A summary of rules, not a profit forecast — don’t buy just because of a green verdict.

• ▲ P/E 9.1 vs peer median 12.2 — cheaper than peers
• ▼ P/S 0.7 — expensive for this stock (over 10 y: from 0.3 to 0.5)
• ▼ EV/EBITDA 8.1 — expensive for this stock (over 4 y: from 3.6 to 11.1)
• ▼ EV/EBITDA 8.1 vs peer median 7.2 — more expensive than peers
• ▼ FCF yield 2.5% — expensive for this stock (over 4 y: from 4.9% to 18.1%)

• ▲ Share count down 14% in 3 y — buybacks grow your stake
• ▲ Piotroski 7/9 — strong financial health
• ▲ ROE 40% — high return on equity
• ▼ Net margin fell: 6.5% → 3.3%
• ▲ Debt / equity 0.68 — moderate debt
• ▲ Free cash flow positive every year

• ▲ Revenue grows 15.6% per year (5 y)
• ▲ Analysts raised the earnings forecast by +59.7% in 90 days

• ▲ Over 6 mo stronger than its sector (XLE) by 40%
• ▲ Price above SMA200 — long-term uptrend
• ▲ SMA50 above SMA200 — trend up
• ▲ Over a year +106% vs S&P 500 +11% — stronger than the market

• ▼ Volatility 32% per year — much higher than the market (13%)
• ▼ Max drawdown in the period -46% — deep

• ▲ Consensus of 19 analysts — buy
• ▼ Insiders selling over 6 mo

• ▲ S&P 500 above SMA200 — the market is in an uptrend
• ▲ Sector (XLE) above SMA200 — in an uptrend
• ▲ Sector (XLE) over 3 mo is stronger than the market by 17%